Using the diffusion of innovations theory to assess socio-technical factors in planning the implementation of an electronic health record alert across multiple primary care clinics

• Main Authors: Ching-Pin Lin, Janelle Guirguis-Blake, Gina A. Keppel, Sharon Dobie, Justin Osborn, Allison M. Cole, Laura-Mae Baldwin
• Format: Article
• Language: English
• Published: BCS, The Chartered Institute for IT 2016-04-01
• Series: Journal of Innovation in Health Informatics
• Subjects: electronic health records; chronic kidney diseases; medication alert systems; adverse drug event; primary care; outpatient clinic
• Online Access: https://hijournal.bcs.org/index.php/jhi/article/view/157
• ISSN: 2058-4555; 2058-4563

Background: Adverse drug events (ADEs) are a leading cause of death in the United States. Patients with stage 3 and 4 chronic kidney disease (CKD) are at particular risk because many medications are cleared by the kidneys. Alerts in the electronic health record (EHR) about drug appropriateness and dosing at the time of prescription have been shown to reduce ADEs for patients with stage 3 and 4 CKD in inpatient settings, but more research is needed about the implementation and effectiveness of such alerts in outpatient settings. Objective:  To explore factors that might inform the implementation of an electronic drug–disease alert for patients with CKD in primary care clinics, using Rogers’ diffusion of innovations theory as an analytic framework. Methods: Interviews were conducted with key informants in four diverse clinics using various EHR systems. Interviews were audio recorded and transcribed. results Although all clinics had a current method for calculating glomerular filtration rate (GFR), clinics were heterogeneous with regard to current electronic decision support practices, quality improvement resources, and organizational culture and structure. Conclusion: Understanding variation in organizational culture and infrastructure across primary care clinics is important in planning implementation of an intervention to reduce ADEs among patients with CKD.